HC
Hopkinson Craig C. Executive
Other M
Insider track record CEO Across 18 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Hopkinson Craig C., Executive. Officer active across 2 companies, notably Alkermes plc.. In total, 36 reports have been published. Breakdown: 0 buy · 11 sells. Total volume traded: €3.3m. History available since 9 June 2021. The latest transaction was disclosed on 1 June 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations 36 total
◇ EVP R&D, Chief Medical Officer · Executives · 1 Jul 2026 · Alkermes plc. 5,000 shares Ordinary Shares SEC:0001520262-26-000103:0
▼ EVP R&D, Chief Medical Officer · Executives · 1 Jul 2026 · Alkermes plc. 8,300 shares Ordinary Shares SEC:0001520262-26-000103:1
▼ EVP R&D, Chief Medical Officer · Executives · 1 Jul 2026 · Alkermes plc. 700 shares Ordinary Shares SEC:0001520262-26-000103:2
◇ EVP R&D, Chief Medical Officer · Executives · 1 Jun 2026 · Alkermes plc. 5,000 shares @ US$19.34 0.0018% mcap 1.2% of flow Ordinary Shares SEC:0001520262-26-000097:0
▼ EVP R&D, Chief Medical Officer · Executives · 1 Jun 2026 · Alkermes plc. 9,000 shares @ US$41.6715 0.0070% mcap 4.6% of flow Ordinary Shares SEC:0001520262-26-000097:1
◇ EVP R&D, Chief Medical Officer · Executives · 26 Feb 2025 · Alkermes plc. 6,866 shares Ordinary Shares SEC:0001127602-25-007313:0
◇ EVP R&D, Chief Medical Officer · Executives · 22 Feb 2025 · Alkermes plc. 12,279 shares Ordinary Shares SEC:0001127602-25-006718:0
● EVP R&D, Chief Medical Officer · Executives · 22 Feb 2025 · Alkermes plc. 5,452 shares @ US$35.32 2.6% of flow Ordinary Shares SEC:0001127602-25-006718:1
◇ EVP R&D, Chief Medical Officer · Executives · 23 Feb 2025 · Alkermes plc. 7,689 shares Ordinary Shares SEC:0001127602-25-006718:2
● EVP R&D, Chief Medical Officer · Executives · 23 Feb 2025 · Alkermes plc. 3,414 shares @ US$35.32 1.6% of flow Ordinary Shares SEC:0001127602-25-006718:3
◇ EVP R&D, Chief Medical Officer · Executives · 18 Feb 2025 · Alkermes plc. 8,896 shares Ordinary Shares SEC:0001127602-25-006033:0
◇ EVP R&D, Chief Medical Officer · Executives · 12 Feb 2025 · Alkermes plc. 87,566 shares @ US$20.03 24.2% of flow Ordinary Shares SEC:0001127602-25-004948:0
◆ EVP R&D, Chief Medical Officer · Executives · 6 Feb 2025 · Alkermes plc. 34,393 shares Ordinary Shares SEC:0001127602-25-003679:0
◇ EVP R&D, Chief Medical Officer · Executives · 30 Jan 2025 · Alkermes plc. 29,156 shares @ US$20.03 8.0% of flow Ordinary Shares SEC:0001127602-25-002645:0
◇ EVP R&D, Chief Medical Officer · Executives · 9 Dec 2024 · Alkermes plc. 12,452 shares @ US$20.03 3.4% of flow Ordinary Shares SEC:0001127602-24-028885:0
▼ EVP R&D, Chief Medical Officer · Executives · 5 Dec 2024 · Alkermes plc. 9,221 shares @ US$31.50 4.0% of flow Ordinary Shares SEC:0001127602-24-028740:0
▼ EVP R&D, Chief Medical Officer · Executives · 4 Dec 2024 · Alkermes plc. 14,349 shares @ US$30.7722 6.0% of flow Ordinary Shares SEC:0001127602-24-028647:0
◇ EVP R&D, Chief Medical Officer · Executives · 11 Nov 2024 · Alkermes plc. 43,058 shares @ US$20.03 11.5% of flow Ordinary Shares SEC:0001127602-24-027044:0
▼ EVP R&D, Chief Medical Officer · Executives · 11 Nov 2024 · Alkermes plc. 58,996 shares @ US$30.0796 23.7% of flow Ordinary Shares SEC:0001127602-24-027044:1
▼ EVP R&D, Chief Medical Officer · Executives · 6 Nov 2024 · Alkermes plc. 10,471 shares @ US$29.5262 4.0% of flow Ordinary Shares SEC:0001127602-24-026629:0
◇ EVP R&D, Chief Medical Officer · Executives · 23 Feb 2024 · Alkermes plc. 7,689 shares Ordinary Shares SEC:0001127602-24-007138:0
◇ EVP R&D, Chief Medical Officer · Executives · 22 Feb 2024 · Alkermes plc. 12,278 shares Ordinary Shares SEC:0001127602-24-006562:0
◇ EVP R&D, Chief Medical Officer · Executives · 18 Feb 2024 · Alkermes plc. 8,897 shares Ordinary Shares SEC:0001127602-24-006170:0
◆ EVP R&D, Chief Medical Officer · Executives · 8 Feb 2024 · Alkermes plc. 46,658 shares Ordinary Shares SEC:0001127602-24-004630:0
◇ EVP R&D, Chief Medical Officer · Executives · 22 Feb 2023 · Alkermes plc. 12,038 shares Ordinary Shares SEC:0001127602-23-007180:0
25 of 36 declarations
Load more (11 remaining) About Hopkinson Craig C. Craig C. Hopkinson is Senior Vice President R&D and Chief Medical Officer of Alkermes plc. He plays a key role in directing research and developing new treatments. His medical expertise is essential for the company's innovation.